Moderate to Severe Chronic Kidney Disease Clinical Trial
Official title:
CARE (Visipaque 320 and Isovue 370 in Cardiac Angiography in REnally Impaired Patients); FOLLOW-UP STUDY
To determine comparative 1-year outcomes in renally impaired patients who previously underwent cardiac angiography with Isovue®-370 or Visipaqueâ„¢ 320 as part of the IOP-104 trial protocol and were evaluable for determination of post-contrast significant renal injury (defined as >25% increase in SCr or >25% increase in cystatin C).
n/a
Observational Model: Case-Only, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02933827 -
Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease
|
Phase 1/Phase 2 |